MALP-2, a TLR2/6 agonist, induced all the three chemokines, indicating excessive inflammation (Figure 3), which is reminiscent of enhanced HIV-1 acquisition during RTI/STIs. This evidence concerns the gene TLR2 and sexually transmitted disease.